What is Hormone Replacement Therapy (HRT)?
Hormone Replacement Therapy (HRT) refers to medical treatments designed to supplement or replace hormones that the human body no longer produces in sufficient quantities. It is utilized across various clinical scenarios where hormonal deficiency causes physical or physiological disruptions.
In this post, we will explore what HRT is, trace the history and current market landscape of HRT for women, and examine the different types of therapy, the delivery methods available, and the key benefits and risks to consider.
Hormone Replacement Therapy for Women
In female, HRT specifically addresses the natural, age-related decline in reproductive hormones (estrogen and progesterone) during perimenopause and post menopause. As ovarian function wanes, the resulting hormonal drop can cause significant physical, emotional, and metabolic changes.
Female HRT aims to replenish these declining hormone levels to alleviate menopausal symptoms, improve overall quality of life, and protect long-term health, such as bone density.
A Brief History and Market Trends of HRT
Hormone replacement therapy (HRT) began in the late 1800s with animal ovarian extracts and became mainstream after the U.S. Food and Drug Administration (FDA) approved Premarin in 1942. After the 2002 Women’s Health Initiative (WHI) trial reported higher risks of heart disease and breast cancer, prescriptions fell by more than half, but subsequent research has refined this view, and HRT is now tailored to each woman’s age and health history.
This renewed confidence is reflected in recent prescribing trends. According to Truveta Research, estrogen-based HRT prescribing more than doubled between 2018 and 2026 among U.S. women, and among women aged 45 to 54, the rate of estrogen-based HRT use rose by 184.2%.
What Is the Key Benefits of HRT?
HRT remains as the most effective treatment for managing the broad spectrum of menopausal transition symptoms, such as:
Vasomotor Symptom Relief: It is the single most effective intervention for reducing the frequency and severity of hot flashes and night sweats.
Urogenital Health: It successfully reverses vaginal dryness, dyspareunia (painful intercourse), and associated localized irritation.
Prevention of Osteoporosis: It preserves bone mineral density, significantly lowering the risk of fractures.
Quality of Life: By mitigating sleep disturbances, mood volatility, and physical discomforts, HRT substantially improves overall daily functioning and well-being.
What Are the Types and Delivery Methods of HRT?
The U.S. FDA classifies hormone replacement therapy into four main types.
Type | Who It's For | Aims |
Combination Therapy | Women with a uterus | Relieves menopausal symptoms while protecting the uterus |
Systemic Estrogen-Alone Therapy | Mainly women who have had a hysterectomy | Relieves menopausal symptoms |
Progestogen-Alone Therapy | Women with a uterus using estrogen-alone therapy | Protects against uterine cancer |
Topical Vaginal Estrogen Therapy | Women with vaginal symptoms | Treats vaginal symptoms locally |
**Adapted from U.S. Food and Drug Administration (FDA), “Hormone Replacement Therapies Can Help Women with Bothersome Menopausal Symptoms,” Consumer Updates (2026).
HRT can be taken in several ways, depending on a woman’s symptoms and health needs. Systemic options such as oral pills, skin patches, gels, and sprays deliver hormones throughout the body, while vaginal creams, tablets, inserts, and rings act locally with minimal absorption into the bloodstream.
Beyond these options, bioidentical hormone replacement therapy (BHRT), which uses hormones chemically identical to those produced by the body, has gained increasing attention. Another option is subcutaneous pellet therapy, in which hormone pellets are implanted beneath the skin for sustained release over several months.
Risks and Safety Considerations of HRT
Concerns about HRT date back largely to the 2002 WHI trial, but subsequent research has since refined that view considerably:
Breast Cancer: The increased risk observed in the WHI combined therapy arm has been largely attributed to the synthetic progestin medroxyprogesterone acetate, while the estrogen-only arm showed a 23% reduction in breast cancer incidence. Any increase in risk is related to treatment duration and declines after discontinuation.
Cardiovascular Health: The Early versus Late Intervention Trial with Estradiol testing (ELITE trial) suggests that the cardiovascular risks identified in the WHI may be specific to conjugated equine estrogens rather than estradiol.
Stroke and Blood Clots: Oral estrogen has been associated with higher risks of stroke and venous thromboembolism (VTE), whereas transdermal estradiol does not appear to confer the same risks, likely because it bypasses liver metabolism.
Compounded Therapies: Custom-compounded BHRT and pellet therapy lack standardization, raising concerns about their safety and dose consistency.
Special Populations: Systemic HRT is generally avoided in breast cancer survivors, and decisions for women with other cancers, breast cancer (BRCA) mutations, or migraines should be individualized.
Overall, current evidence favors low-dose, non-oral, estradiol-based regimens, tailored to each woman’s health profile through shared decision-making with a healthcare provider.
What’s Next?
Now that we have a clearer understanding of what HRT is, the next question is: how do clinicians decide whether HRT is right for someone, and how is treatment monitored? In our next post, we will break down the essential hormone markers worth testing in women’s HRT, one by one, and explain why each of them matters.
References:
Comments